Loading...

Medical tourism in Taiwan helped by rise in non-Chinese patients

Image

07-Nov-16 Despite a decline in Chinese tourists visiting Taiwan, the medical tourism industry has enjoyed steady growth, thanks to visitors from Europe, North America, Hong Kong and Macau. The number of visitors and the output of the industry have been growing steadily. From 2008 to last year, 63 medical institutions saw the foreign patients increase from 68,000 to 300,000. [image: Medical Tourism Magazine]

Read More

China’s growing contribution to health at home and on the global stage

Image

18-Nov-16 2016 marked another major milestone in China, as health became an explicit national priority under the Healthy China 2030 plan. This is an exceptional recognition of the political power of health. But some formidable new threats have arrived. Population-wide increases in body weight warn of a wave of lifestyle-related diseases including heart disease, diabetes and diet-related cancers. [image: China Topix]

Read More

MetLife Hong Kong launches overseas medical treatment insurance

Image

15-Nov-16 MetLife Hong Kong has announced the launch of its new MetLife Borderless Best-in-Health Benefit, which provides seamless overseas access to world-class medical advice and treatment. The plan connects customers to overseas medical experts for a case review and second opinion, and pays for overseas medical treatment costs, as well as travel and accommodation. [image: MetLife Hong Kong]

Read More

Malaysia's IHH sells 30% of unit to Chinese insurer

Image

14-Nov-16 IHH Healthcare, the largest Malaysia-based hospital operator by market capitalization, has divested a 29.9% stake in its indirectly held unit PCH Holding to Chinese firm TK Healthcare Investment. IHH's subsidiary, Parkway Group Healthcare will still hold a 70.1% stake in PCH Holding. PCH, formerly known as Parkway China Holding, holds a chain of clinics and hospitals in China. [image: IHH Healthcare]

Read More

Biomedical industry development project approved in Taiwan

Image

11-Nov-16 The Taiwan government plans to invest NTD11 bn (USD374 mn) in the biomedical industry in 2017 to develop large-scale healthcare firms, new drugs and new medical devices. The project aims to relax investment and recruitment regulations to lure and retain foreign capital and talent, and to encourage local businesses to acquire international companies and develop foreign markets. [image: CNA]

Read More
Share